Breaking Down Arcus Biosciences: 4 Analysts Share Their Views
Breaking Down Arcus Biosciences: 4 Analysts Share Their Views
解讀Arcus Biosciences：4位分析師分享他們的看法
During the last three months, 4 analysts shared their evaluations of Arcus Biosciences (NYSE:RCUS), revealing diverse outlooks from bullish to bearish.
在過去三個月中，有4名分析師分享了他們對Arcus Biosciences (NYSE:RCUS) 的評價，展現了從看多到看淡的不同態度。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他們最近的評級快照，展示了情緒在過去30天中的演變情況，並將其與之前的月份進行比較。
Analysts have recently evaluated Arcus Biosciences and provided 12-month price targets. The average target is $34.25, accompanied by a high estimate of $44.00 and a low estimate of $25.00. Highlighting a 9.27% decrease, the current average has fallen from the previous average price target of $37.75.
分析師們最近對Arcus Biosciences進行了評估，並提供了12個月的價格目標。平均目標價格爲34.25美元，最高目標爲44.00美元，最低目標爲25.00美元。當前平均目標價格已經下降了9.27%，從之前的37.75美元的平均目標價格下降了。
Interpreting Analyst Ratings: A Closer Look
解讀分析師評級：更深入的了解
The analysis of recent analyst actions...
最近分析師行...
登入免費觀看全文
登入/註冊